Tavexia Lifecare
BSE 539519
6 stories, newest first.
- Board approves acquisition of 60% controlling stake in Meyonex Pharmaceuticals for ₹67.19 Crore
- Board approves 60% controlling stake in Meyonex Pharmaceuticals via ₹67.19 Crore share subscription
- Board approves proposed acquisition of 60% stake in Meyonex Pharmaceuticals
- Board approves up to 60% stake in Meyonex Pharmaceuticals via fresh equity subscription
- Board to Meet on 7 October 2026 to Further Deliberate Proposed Acquisition of up to 60% in Meyonex Pharmaceuticals
- Tavexia Lifecare Ltd promoter sells 0.065% stake, holding falls to 3.647%
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.